Bulletin
Investor Alert

Market Pulse Archives

Oct. 14, 2020, 7:32 a.m. EDT

NIH confirms trial for Lilly antibody treatment is paused

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Eli Lilly & Co. (LLY)
  • X
    Gilead Sciences Inc. (GILD)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Eli Lilly & Co. /zigman2/quotes/200106384/composite LLY +1.87% were down 0.5% in premarket trading on Wednesday, the day after the drug maker confirmed that a clinical trial for its COVID-19 antibody treatment in combination with remdesivir had been paused. Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD -0.06% received emergency authorization for remdesivir in May as a COVID-19 therapeutic. The National Institutes of Health, which is sponsoring the study assessing the investigational combination treatment, on Tuesday night confirmed that enrollment in the trial had been paused, saying the data safety and monitoring board on Tuesday noticed that the study had "reached a predefined boundary for safety at day five." The trial will continue to collect data and monitor the current 326 participants who have received treatment so far. (Half of those participants received placebo, though all participants get remdesivir.) On Oct. 26, the board will recommend whether enrollment can resume. Lilly's stock is up 14.2% so far this year, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.30% has gained 8.7%.

/zigman2/quotes/200106384/composite
US : U.S.: NYSE
$ 206.14
+3.79 +1.87%
Volume: 6.13M
Jan. 22, 2021 4:00p
P/E Ratio
33.74
Dividend Yield
1.65%
Market Cap
$197.19 billion
Rev. per Employee
$663,777
loading...
/zigman2/quotes/210293917/composite
US : U.S.: Nasdaq
$ 66.94
-0.04 -0.06%
Volume: 4.91M
Jan. 22, 2021 4:00p
P/E Ratio
69.44
Dividend Yield
4.06%
Market Cap
$83.91 billion
Rev. per Employee
$1.89M
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,841.47
-11.60 -0.30%
Volume: 2.29B
Jan. 22, 2021 4:59p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.